Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
6	5	Search

2025	Recent Advances of Quinoline‐Based Small Molecules as Kinase Inhibitors (2020–2024) ChemMedChem Sara Sultan, Ruba A. Zenati, Hanan S. Anbar, Mohammed I. El‐Gamal, Mohammad H. Semreen
2022	EGFR and COX-2 Dual Inhibitor: The Design, Synthesis, and Biological Evaluation of Novel Chalcones Molecules Arafa Musa, Ehab M. Mostafa, Syed Nasir Abbas Bukhari, Nasser Hadal Alotaibi, Ahmed H. El-Ghorab, Amr Farouk, AbdElAziz A. Nayl, Mohammed M. Ghoneim, Mohamed A. Abdelgawad
2021	Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights Drug Design, Development and Therapy Mohamed A Abdelgawad, Arafa Musa, Atiah H Almalki, Sami I Alzarea, Ehab M Mostafa, Mostafa M Hegazy, Gomaa Mostafa-Hedeab, Mohammed M Ghoneim, Della GT Parambi, Rania B Bakr, Nayef S Al-Muaikel, Abdullah S Alanazi, Metab Alharbi, Waqas Ahmad, Syed NA Bukhari, Mohammad M Al-Sanea
2021	A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico Insights Molecules Mohammad M. Al-Sanea, Ahmad J. Obaidullah, Mohamed E. Shaker, Garri Chilingaryan, Mohammed M. Alanazi, Nawaf A. Alsaif, Hamad M. Alkahtani, Sultan A. Alsubaie, Mohamed A. Abdelgawad
2020	Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights Bioorganic & Medicinal Chemistry Mohammad M. Al-Sanea, Ahmed Elkamhawy, Sora Paik, Kyeong Lee, Ahmed M. El Kerdawy, Bukhari Syed Nasir Abbas, Eun Joo Roh, Wagdy M. Eldehna, Heba A.H. Elshemy, Rania B Bakr, Ibrahim Ali Farahat, Abdulaziz I. Alzarea, Sami I. Alzarea, Khalid S. Alharbi, Mohamed A. Abdelgawad
	Additional cited-by details will be shown when available from Crossref